Larvol Delta - Phase-I-Study-of-SYD985-With-Niraparib-in-Patients-With-Solid-Tumors

trastuzumab duocarmazine (SYD985) - Byondis, Medac

Zejula (niraparib) - GSK, J&J, Takeda

http://clinicaltrials.gov/ct2/show/NCT04235101

Jul 5, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next